Case Study: Study Start-Up and Enrollment

Novella Clinical’s rapid start-up and enrollment sets the course for successful execution of this Phase II prostate cancer drug trial

Novella Clinical was approached by a clinical-stage biopharmaceutical company to run its Phase II prostate cancer drug trial in the US. The sponsor learned of Novella’s particular expertise in Genitourinary (GU) oncology, having supported the pivotal work for two prostate cancer drugs approved within the past three years, and received positive referrals from colleagues and clinics that had worked with Novella. For the Phase II trial, the sponsor was searching for a CRO with an oncology-dedicated group, specific prostate cancer expertise, an ability to be flexible in implementation, and a willingness to provide transparency in the trial’s execution.